Trial Profile
Correta Trial (Corticosteroid Reduction with Tacrolimus): prospective Brazilian multicenter, randomized trial of early corticosteroid reduction versus regular corticosteroid dosage maintenance on a tacrolimus [Prograf] and mycophenolate mofetil [Cellcept] immunosuppression regimen kidney transplant recipients,
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2010
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Tacrolimus (Primary) ; Prednisone
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms CORRETA
- 21 Jan 2010 Results published in Clinical Transplantation.
- 14 Nov 2007 New trial record.